» Articles » PMID: 35981695

Iron Overload Promotes Intervertebral Disc Degeneration Via Inducing Oxidative Stress and Ferroptosis in Endplate Chondrocytes

Overview
Date 2022 Aug 18
PMID 35981695
Authors
Affiliations
Soon will be listed here.
Abstract

Iron overload is a common phenomenon in the elderly population. Many clinical studies have indicated an association between iron overload and the incidence and pathological progression of intervertebral disc degeneration (IVDD). However, the role and underlying mechanism by which iron participates in the progression of IVDD has not yet been reported. In the present study, we aimed to elucidate the connection between iron overload and IVDD, and explore the underlying mechanisms of disease. Firstly, a clinical epidemiology study was conducted and revealed that iron overload is an independent risk factor for human IVDD. To elucidate the role of iron overload in IVDD, an iron overload mouse model was established, and we observed that iron overload promoted IVDD and cartilage endplate degeneration in a dose dependent manner. Endplate chondrocytes were further isolated and treated with FAC to mimic iron overload in vitro. Excess iron significantly promoted mineralization of endplate chondrocytes in addition to their degeneration via oxidative stress. Moreover, a high dose of excess iron promoted chondrocytes ferroptosis. An iron chelator (DFO), an antioxidant (NAC) and a ferroptosis inhibitor (Fer-1) demonstrated effective inhibition of endplate chondrocyte degeneration induced by iron overload, and our in vivo studies further demonstrated that DFO, NAC and Fer-1 could rescue high dose iron-induced IVDD and cartilage endplate calcification. In conclusion, our results indicate that iron overload is strongly associated with the onset and development of IVDD via oxidative stress and ferroptosis. Inhibiting oxidative stress or ferroptosis could therefore be promising therapeutic strategies for IVDD induced by iron overload.

Citing Articles

Piezo1 promotes intervertebral disc degeneration through the Ca/F-actin/Yap signaling axis.

Peng F, Sun M, Jing X, Chen F, Cao T, Li Z Mol Med. 2025; 31(1):90.

PMID: 40057686 PMC: 11889814. DOI: 10.1186/s10020-025-01147-z.


Gallic acid protects intervertebral disc cells from ferroptosis and alleviates intervertebral disc degeneration by regulating key factors of oxidative stress.

Zhu Z, Huang Z, Zhang C, Xu B, Chen H, Pei S Front Pharmacol. 2025; 16:1501725.

PMID: 39963245 PMC: 11830718. DOI: 10.3389/fphar.2025.1501725.


Humanin reduces nucleus pulposus cells ferroptosis to alleviate intervertebral disc degeneration: An in vitro and in vivo study.

Zhu D, Wang Z, Li Y, Chen S, Kang X J Orthop Translat. 2025; 50:274-294.

PMID: 39902261 PMC: 11788685. DOI: 10.1016/j.jot.2024.12.002.


Targeting ferroptosis to enhance the efficacy of mesenchymal stem cell-based treatments for intervertebral disc degeneration.

Xu Y, Xu X, Chai R, Wu X Int J Biol Sci. 2025; 21(3):1222-1241.

PMID: 39897051 PMC: 11781166. DOI: 10.7150/ijbs.107021.


The effect of platelet-rich plasma on ferroptosis of nucleus pulposus cells induced by Erastin.

Lian S, Huang J, Zhang Y, Ding Y Biochem Biophys Rep. 2025; 41():101900.

PMID: 39811190 PMC: 11732229. DOI: 10.1016/j.bbrep.2024.101900.